News from us and our partners

Tags

Topics

0 results

News
19 October, 2017
Pixium Vision receives approval for First-in-Human Clinical Trial of PRIMA, its miniaturized sub-retinal implant
News
18 October, 2017
Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors
News
11 October, 2017
Shockwave Medical Announces $35 Million in New Financing
News
9 October, 2017
la Relève" Les Echos
News
3 October, 2017
Noxxon publie des données précliniques de preuve de concept relatives à l'association du composé phare NOX-A12 à des inhibiteurs de point de contrôle
News
30 September, 2017
Nucana plc announces pricing of initial public offering
News
29 September, 2017
Noxxon provides update ongoing phase 1/2 clinical trial with lead program NOX-A12
News
27 September, 2017
Henrijette Richter appointed Managing Partner of Sofinnova Partners
News
27 September, 2017
Henrijette Richter est promue Managing Partner de Sofinnova Partners
News
19 September, 2017
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
News
19 September, 2017
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
News
19 September, 2017
ProQR receives Orphan Drug Designation from FDA
News
12 September, 2017
Sofinnova Partners announces DNA Script’ successful Series A fundraising of €11 M
News
15 June, 2017
ProQR R&D day Highlights Progress on Pipeline and Introduces Axiomer®, a novel proprietary RNA Technology
News
8 June, 2017
Avantium N.V. proudly announces that a BBI subsidy of EUR 25 million has been granted to the Industry Consortium “PEFerence”. The consortium, consisting of 11 companies including Synvina, Avantium, BA
News
8 June, 2017
ProQR to present QR-010 data at the European Cystic Fibrosis Society Conference and provides an update on the ongoing Phase 1b trial

Pixium Vision receives approval for First-in-Human Clinical Trial of PRIMA, its miniaturized sub-retinal implant

Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors

Shockwave Medical Announces $35 Million in New Financing

la Relève" Les Echos

Noxxon publie des données précliniques de preuve de concept relatives à l'association du composé phare NOX-A12 à des inhibiteurs de point de contrôle

Nucana plc announces pricing of initial public offering

Noxxon provides update ongoing phase 1/2 clinical trial with lead program NOX-A12

Henrijette Richter appointed Managing Partner of Sofinnova Partners

Henrijette Richter est promue Managing Partner de Sofinnova Partners

Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs

Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs

ProQR receives Orphan Drug Designation from FDA

Sofinnova Partners announces DNA Script’ successful Series A fundraising of €11 M

ProQR R&D day Highlights Progress on Pipeline and Introduces Axiomer®, a novel proprietary RNA Technology

Avantium N.V. proudly announces that a BBI subsidy of EUR 25 million has been granted to the Industry Consortium “PEFerence”. The consortium, consisting of 11 companies including Synvina, Avantium, BA

ProQR to present QR-010 data at the European Cystic Fibrosis Society Conference and provides an update on the ongoing Phase 1b trial